Abstract: |
Serological analysis of recombinant cDNA expression libraries (SEREX) using tumor mRNA and autologous patient serum provides a powerful approach to identify immunogenic tumor antigens. We have applied this methodology to a case of esophageal squamous cell carcinoma and identified several candidate tumor targets. One of these, NY-ESO-1, showed restricted mRNA expression in normal tissues, with high-level mRNA expression found only in testis and ovary tissues. Reverse transcription-PCR analysis showed NY-ESO-1 mRNA expression in a variable proportion of a wide array of human cancers, including melanoma, breast cancer, bladder cancer, prostate cancer, and hepatocellular carcinoma. NY-ESO-1 encodes a putative protein of Mr 17,995 having no homology with any known protein. The pattern of NY-ESO-1 expression indicates that it belongs to an expanding family of immunogenic testicular antigens that are aberrantly expressed in human cancers in a lineage- nonspecific fashion. These antigens, initially detected by either cytotoxic T cells (MAGE, BAGE, GAGE-1) or antibodies [HOM-MEL-40(SSX2), NY-ESO-1], represent a pool of antigenic targets for cancer vaccination. |
Keywords: |
adult; human tissue; sequence analysis; case report; carcinoma, squamous cell; conference paper; polymerase chain reaction; neoplasms; proteins; reverse transcription polymerase chain reaction; gene expression; membrane proteins; gene product; gene library; tumor antigen; ovary; cloning, molecular; gene expression regulation, neoplastic; amino acid sequence; molecular sequence data; antigens, neoplasm; tissue distribution; messenger rna; rna, messenger; antigen detection; base sequence; blotting, northern; molecular weight; esophagus carcinoma; serology; antibody; testis; esophageal neoplasms; normal human; complementary dna; dna, complementary; testis antigens; cancer; humans; human; male; female; priority journal
|